Ledger.Open graph →
SEC Form D · filed December 12, 2024

NeuroSense Therapeutics Ltd

Offering
$5.0M
Sold
$5.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
HERZLIYA, L3
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (11)

General Partner Of The General Partner Harel · Herzliya, L3Exec · DirectorCary Claiborne · Herzliya, L3DirectorMark Leuchtenberger · Herzliya, L3DirectorNiva Russek-Blum · Herzliya, L3ExecChristine Pelizzari · Herzliya, L3DirectorRevital Mandil-Levin · Herzliya, L3DirectorOr Eisenberg · Herzliya, L3ExecHagit Binder · Herzliya, L3ExecAlon Ben-Noon · Herzliya, L3Exec · DirectorRoy Golan · Herzliya, L3DirectorFerenc Tracik · Herzliya, L3Exec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗